Showing results (381-390 of 471) with videos related to

Sort By:
Pageof 48
Diabetes|December 24, 2009
Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetesAxel Haupt, Claus Thamer, Martin Heni, et al.
Plos One|December 15, 2015
Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory MarkersMartin Kächele, Anita M Hennige, Jürgen Machann, et al.
Nutrients|July 16, 2020
Normalized Indices Derived from Visceral Adipose Mass Assessed by Magnetic Resonance Imaging and Their Correlation with Markers for Insulin Resistance and PrediabetesJürgen Machann, Norbert Stefan, Robert Wagner, et al.
Investigative Radiology|November 13, 2008
T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritinNina F Schwenzer, Jürgen Machann, Michael M Haap, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2008
Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance studyClaus Thamer, Jürgen Machann, Norbert Stefan, et al.
Plos One|November 10, 2012
Heterogeneity of the Stearoyl-CoA desaturase-1 (SCD1) gene and metabolic risk factors in the EPIC-Potsdam studyMaria Arregui, Brian Buijsse, Norbert Stefan, et al.
The American Journal of Clinical Nutrition|February 9, 2008
Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individualsJuraj Koska, Norbert Stefan, Paska A Permana, et al.
Diabetes|May 29, 2002
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humansNorbert Stefan, Barbora Vozarova, Tohru Funahashi, et al.
Molecular Metabolism|July 3, 2015
Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytesLucia Berti, Martin Irmler, Marty Zdichavsky, et al.
Obesity (Silver Spring, Md.)|May 26, 2017
Genetic determination of body fat distribution and the attributive influence on metabolismEllen Fehlert, Róbert Wagner, Caroline Ketterer, et al.
Pageof 48